About Aurum Biosciences
Aurum Biosciences is a company based in Glasgow (United Kingdom) founded in 2015. Aurum Biosciences has raised $6.3 million across 3 funding rounds from investors including Scottish Enterprise, Infinion BioPharma and InnoScot. The company has 6 employees as of March 31, 2022. Aurum Biosciences offers products and services including ABL-101 and ABL-101 Platform. Aurum Biosciences operates in a competitive market with competitors including Basking Biosciences, Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma and ZZ Biotech, among others.
- Headquarter Glasgow, United Kingdom
- Employees 6 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aurum Biosciences Limited
- Date of Incorporation 01 Nov, 2010
- Jurisdiction GLASGOW, SCOTLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.3 M (USD)
in 3 rounds
-
Latest Funding Round
$926.33 K (USD), Series A
Jan 31, 2024
-
Investors
Scottish Enterprise
& 7 more
-
Employee Count
6
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aurum Biosciences
Aurum Biosciences offers a comprehensive portfolio of products and services, including ABL-101 and ABL-101 Platform.
Injectable for oxygen delivery in stroke and spinal injury treatment
Platform for therapeutics and diagnostics in inflammation and oncology
People of Aurum Biosciences
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Aurum Biosciences
Aurum Biosciences has successfully raised a total of $6.3M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $926.33 thousand completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aurum Biosciences
Aurum Biosciences has secured backing from 8 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Scottish Enterprise, Infinion BioPharma and InnoScot.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage Scottish companies are supported with investment and expertise.
|
Locked | Locked | Locked | |
|
Supports healthcare innovation by assessing ideas, protecting IP, and facilitating commercial deals.
|
Locked | Locked | Locked | |
|
Business development and leadership training programs are offered to companies.
|
Locked | Locked | Locked |
Investor details for Aurum Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aurum Biosciences
Investment portfolio details for Aurum Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aurum Biosciences
Detailed financials for Aurum Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aurum Biosciences Comparisons
Peer comparison for Aurum Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aurum Biosciences
Aurum Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Basking Biosciences, Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma and ZZ Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for ischemic stroke treatment are developed.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for ischemic stroke treatment using monoclonal antibodies.
|
|
| Locked | Locked | Locked |
Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury.
|
|
| Locked | Locked | Locked |
Drugs for haemorrhagic stroke and intracranial haemorrhage are developed.
|
|
| Locked | Locked | Locked |
Genetically engineered proteins for stroke and brain disorders are developed.
|
Detailed competitors of Aurum Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aurum Biosciences
Complete news archive for Aurum Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurum Biosciences
Aurum Biosciences was founded in 2015.
Aurum Biosciences is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Aurum Biosciences is a funded company, having raised a total of $6.3M across 3 funding rounds to date.
As of Mar 31, 2022, the latest employee count at Aurum Biosciences is 6.
Aurum Biosciences was founded in 2015 in Glasgow, United Kingdom, as a biopharmaceutical company. Novel perfluorocarbon-based oxygen carriers, known as Oxycyte, are combined with proprietary software and MRI imaging to form the Glasgow Oxygen Level Dependent (GOLD) technology. This is advanced through preclinical development and clinical studies for acute ischaemic stroke, serving as both a diagnostic tool and therapeutic option, with potential follow-on indications.
Aurum Biosciences's top competitors include Acticor Biotech, Remedy Pharmaceuticals and Basking Biosciences.
Aurum Biosciences offers ABL-101 and ABL-101 Platform.
Aurum Biosciences has 8 investors. Key investors include Scottish Enterprise, Infinion BioPharma, InnoScot, TRICAPITAL Angels, and Celestine Santosh.